Search Results - "Ficara, C"

Reengineering patient care: a multidisciplinary approach--an interview by Ficara, C, Elberth, W

Get more information

Making a transition from quality assurance to quality improvement by Caramanica, L, Ficara, C, Moynihan, P

“…Health care leaders now recognize the importance of adding continuous quality improvement activities and the measurement of clinical outcomes to their…”
Get more information

Long‐term captopril treatment in moderate to severe hypertension by Santucci, A, Aguglia, F, Mattia, G, Ficara, C, Balsano, F

“…1 The long‐term effects of the oral angiotensin‐converting enzyme inhibitor captopril with the addition of a diuretic (chlorthalidone) were examined in 16…”
Get full text

Effects of captopril on blood pressure and renin-angiotensin-aldosterone system in hypertensive subjects after inhibition of renal vasodilative system by Santucci, A, Aguglia, F, De Mattia, G, Cammarella, I, Giordano, M, Gnecchi, M, Trinchieri, F, Ficara, C

“…The aim of this study is to contribute to the understanding of the probable role of the renin-angiotensin-aldosterone, the kallikrein-kinins and the…”
Get more information

Clinical experience with a new antihypertensive drug (captopril SQ 14.225), an oral inhibitor of converting enzyme by Santucci, A, Aguglia, F, Ficara, C

Get more information

Effect of angiotensin converting enzyme inhibition on platelet angiotensin II content by Santucci, A, Ferri, C, Leonetti Luparini, R, Del Porto, M A, De Angelis, C, Ficara, C, Balsano, F

“…The effect of captopril treatment on platelet angiotensin II levels was evaluated in 12 patients with essential hypertension. Captopril significantly lowered…”
Get more information

Relationship between vasopressin and the renin-angiotensin-aldosterone system in essential hypertension: effect of converting enzyme inhibitor on plasma vasopressin by Santucci, A, Leonetti Luparini, R, Ferri, C, Ficara, C, Giarrizzo, C, Balsano, F

“…The effect of the chronic administration of captopril on plasma levels of vasopressin (PVP) were studied in 14 patients with moderate essential hypertension…”
Get more information

Role of the renin-angiotensin-aldosterone system in ascitic hepatic cirrhosis. Effects of inhibition of angiotensin I converting enzyme by Santucci, A, Aguglia, F, De Mattia, G, Cammarella, I, Trinchieri, F, Giordano, M, Gnecchi, M, Ficara, C

Get more information

Behavior of the renin-angiotensin-aldosterone system and urinary kallikrein in patients with ascitic hepatic cirrhosis by Aguglia, F, Santucci, A, De Mattia, G, Gnecchi, M, Trinchieri, F, Giordano, M, Cammarella, I, Ficara, C

Get more information

Effects on long-term treatment with indapamide in subjects with essential arterial hypertension by Aguglia, F, Santucci, A, Cicconetti, P, Ficara, C, Costanzi, S

Get more information

Effects of medium- and long-term treatment with nicardipine on arterial blood pressure, hemodynamics and renal function in patients with arterial hypertension of mild and moderate degree by Onofri, R, Leonetti Luparini, R, Giarrizzo, C, Alessandri, C, Ficara, C, Ferri, C, Caparra, A, Santucci, A

Get more information

Relationship of plasma levels of angiotensin II and intraplatelet content of the peptide by Del Porto, M A, Ferri, C, De Angelis, C, Leonetti Luparini, R, Giarrizzo, C, Ficara, C, Santucci, A

Get more information

Platelet content of vasoactive substances: identification of angiotensin II by Leonetti Luparini, R, Ferri, C, Del Porto, M A, De Angelis, C, Ficara, C, Giarrizzo, C, Santucci, A

Get more information